Autorisation d’accès précoce refusée à la spécialité TEZSPIRE (Tézépélumab).
See also
Décision d'accès précoce
22/12/2022
eNrdWE1z2jAQvfMrGA69GfNhEtMaMi1NWmaSKSVh2umFEfICokJy9AEkv74yhoZ0TGkEOjQXRkjy27X09u2uo4vVnBYXICThrFWqliulIjDMY8ImrdLg7soLSxftQjRDC1TEFEnZKqXj8ggQk+XvN9cfwewGUWoXihEfzQCrZ/u0IrT8GcnpDUrSPcVowUlcnIOa8rhVSrRazxYjqYSx2V5y8VMmCEPkb2Z2V2fDYHc+8lOwf0DVEsQ1YpNcUGBWmFgLAUx1kIIJFw+50ImIq8NaMzyrNkMrI0T2QXItMPSQmvYEX5AY4lxbY0QlWBkZL+NbEAsKKjWSC+7P8FxagaMZWvXhvpvv9Huz2lEr5VW86nkzqJ0FQVCvN5pWpsTOUeXTx7yEnwzr9WYYhOc+MD8GTFLqe6xWqdW8SnAe+jH2Jcy9WHvVhmc2wHwkwFuvmznMKYUJmAWPIm+KtALP/HBB1HpSImYGCRfKDDwBYy03e2OYI2aGsYcwBuklwoQO3iLJxLiCaIqi4FEmRIAlY3qpbeqIK0R2nvPekR0B9wc5GROZUPRQnsnE9qiQQGYZhFEndy+SvsGdMHpJzZn9gc80pf4LvR5s1MyRx6lYdrhmao+oXfVtD6LDTWys9t+onQ6r1YaLBOTpYB85y89BPT2iBNsKrZFCDVIN+t39Ovv6JeoDkjAQ7jTqG2ExX8rTa98u1xx5v74XeqCcaDSsQ/uHIfaebHypBU/AN6pI5DFi12VjfqzMmVjJh9pGyisPknXJyjGisKdo9Sx12ETHtsZ2Fn/uYjtbyAX9dHlnS9qvGsTD7fpvLjSJW7/pZpekXGQ+EyKHHM/EJHW+0gib9eANmifvtt1Qy7LzyUD/2viM8bAWngdh3a7t0SJfAKdKJfKt7y+Xy/IUySxIy2Pxv6XNi9x7OcXdmBz1RDV3/aKTSi6rbLP85Mj1UVZ4vIxctqpyqNY7tn/ZPL/pk3JtKKHhiLvIEpCzNNG9PH3meWpenLnde6Z/7sysGw2kjIi5KjX1KD9rHJXrzL2yK2EE4st4TPZ8yNvLy8jPPiK2C5GffkBsF34BRvvRVA==
LT1bgzqPDxYZrVyP